Iloperidone Sublicense to Novartis Pharma AG (Details Textual)
|
12 Months Ended |
---|---|
Dec. 31, 2014
|
|
Minimum [Member] | |
Operating Leased Assets [Line Items] | |
Percentage Of Next Slab Of Annual Sales For Calculating Net Royalty |
8.00%ttnp_PercentageOfNextSlabOfAnnualSalesForCalculatingNetRoyalty / us-gaap_RangeAxis = us-gaap_MinimumMember |
Maximum [Member] | |
Operating Leased Assets [Line Items] | |
Percentage Of Next Slab Of Annual Sales For Calculating Net Royalty |
10.00%ttnp_PercentageOfNextSlabOfAnnualSalesForCalculatingNetRoyalty / us-gaap_RangeAxis = us-gaap_MaximumMember |
X | ||||||||||
- Definition
Percentage of next slab of annual sales for calculating net royalty. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|